Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study will evaluate the use of Heated Intraperitoneal Chemotherapy (HIPEC) for primary treatment of ovarian cancer at the time of surgical debulking, to assess if intravenous (IV) chemotherapy can be started within 42 days of HIPEC and cytoreduction. All patients will receive cytoreductive surgery followed by a one-time closed HIPEC with cisplatin at 41-43 degrees Celsius for 90 minutes in the operating room. This is followed by 6 cycles of intravenous carboplatin and paclitaxel on an outpatient basis.
Epistemonikos ID: 95a115358093c921b4b928c23ae17aac2b88a36a
First added on: May 21, 2024